StockData
Intuitive Surgical Inc logo

Intuitive Surgical Inc (ISRG) operating KPIs

ISRGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 17/3023% above fair value
$432.01−16.75 (-3.73%)

Close on Oct 30, 2026Market cap $152.62BP/E 49.5Yield –

Intuitive Surgical intuitive-Fosun Joint Venture (China, 40% NCI) — Net Income (Loss) Attributable to Noncontrolling Interest ($M) ($M)

Form 10-Q / 10-K Income Statement & Note 2 (XBRL NetIncomeLossAttributableToNoncontrollingInterest)

Latest, Q3 2026
1.60
Period ended Sep 30, 2026
Change on a year earlier
-66.7%
4.80 in Q3 2025
History
39 quarters
Since Q1 2017
Sources
34
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedIntuitive-Fosun Joint Venture (China, 40% NCI) — Net Income (Loss) Attributable to Noncontrolling Interest ($M) ($M)Year on yearSource
Q3 2026Sep 30, 20261.60-66.7%SEC Filing (0001035267-26-000071) ↗
Q2 2026Jun 30, 20265.10-12.1%SEC Filing (0001035267-26-000058) ↗
Q1 2026Mar 31, 20264.50-15.1%SEC Filing (0001035267-26-000032) ↗
Q4 2025Dec 31, 20254.70+104.3%SEC Filing (0001035267-26-000010) ↗
Q3 2025Sep 30, 20254.80-12.7%SEC Filing (0001035267-26-000071) ↗
Q2 2025Jun 30, 20255.80+26.1%SEC Filing (0001035267-26-000058) ↗
Q1 2025Mar 31, 20255.30+112.0%SEC Filing (0001035267-26-000032) ↗
Q4 2024Dec 31, 20242.30-48.9%SEC Filing (0001035267-26-000010) ↗
Q3 2024Sep 30, 20245.50+34.1%SEC Filing (0001035267-25-000209) ↗
Q2 2024Jun 30, 20244.60-11.5%SEC Filing (0001035267-25-000192) ↗
Q1 2024Mar 31, 20242.50-54.5%SEC Filing (0001035267-25-000109) ↗
Q4 2023Dec 31, 20234.50-61.9%SEC Filing (0001035267-26-000010) ↗
Q3 2023Sep 30, 20234.10+485.7%SEC Filing (0001035267-24-000247) ↗
Q2 2023Jun 30, 20235.20-10.3%SEC Filing (0001035267-24-000207) ↗
Q1 2023Mar 31, 20235.50+44.7%SEC Filing (0001035267-24-000137) ↗
Q4 2022Dec 31, 202211.8+461.9%SEC Filing (0001035267-25-000017) ↗

Breakdown

What makes up intuitive-fosun joint venture (china, 40% nci) — net income (loss) attributable to noncontrolling interest ($m)

Cite this data

StockData. (2026). Intuitive Surgical Intuitive-Fosun Joint Venture (China, 40% NCI) — Net Income (Loss) Attributable to Noncontrolling Interest ($M) ($M), quarterly Q1 2017–Q3 2026 [Data set]. Compiled from Intuitive Surgical SEC filings and investor materials. https://stockdatahq.com/stocks/isrg/kpis/jv-nci-net-inc

See every metric in the Intuitive Surgical KPI table. Data updated Oct 28, 2026.